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ABSTRACT
Substrate specificity was investigated among four o f the eukaryotic, widely expressed 
subtilisin-like proprotein convertases (SPCs): furin, PACE4, PC5, and PC7. Through 
site-directed mutagenesis, amino acid substitutions in the P L  position o f pro-von 
W illebrand Factor (pro-vWF), a proprotein processed by each SPC, were made by 
incorporating three different hydrophobic residues at this site: alanine, phenylalanine, and 
glycine. Results from in vivo and in vitro studies demonstrate that the presence o f a P L  
phenylalanine significantly impairs cleaving ability of furin, PACE4, and PC5. These 
results suggest the residue residing in the P L  position does not solely determine substrate 
specificity of these SPCs. PC7 showed approximately equivalent levels o f activity versus 
wild type pro-vWF and all three pro-vWF mutant substrates, possibly indicating a broader 
substrate range for PC7.
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Introduction
In eukaryotic cells, polypeptides are produced at free cytoplasmic ribosomes or at 
ribosomes bound to the endoplasmic reticulum (e.r.). Proteins translated on the latter are 
transported into the constitutive secretory pathway, which is composed o f the e.r., Golgi 
apparatus, trans-Golgi network (TGN), and secretory vesicles. These proteins may 
remain localized within the secretory system, may enter secretory vesicles and be released 
from the cell, or may move to the cell surface. Proteins that enter the secretory pathway 
typically undergo extensive post-translation modification. These post-translational 
modifications include glycosylation, phosphorylation, and endoproteolysis. For general 
overviews o f secretory system protein trafficking and modifications see Lewin (2000) or 
Alberts et al. (1994).
Endoproteolysis, the sequence-specific hydrolysis o f one or more peptide bonds in a 
protein, is o f critical regulatory significance. Many proteins are activated as a result o f 
endoproteolysis. The inactive precursor protein is usually referred to as a proprotein or 
zymogen. Many proproteins are activated by endoproteolytic removal o f a short stretch 
o f amino acids at the amino terminus called the propeptide; however, an activating 
endoproteolytic event may occur at any position in a protein (Alberts et al., 1994). 
Endoproteolysis is catalyzed by endoproteases, a group o f enzymes that process 
proproteins into their mature, functional form. The regulatory significance o f 
endoproteolysis and endoproteases has been known for decades; for example, blood 
clotting has been shown to involve a sequential cascade o f endoproteolytic events 
(reviewed by Kalafatis et al., 1997). Many proteins that enter the secretory pathway, such
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as hormones, growth factors, receptors, and extracellular matrix proteins, have been 
discovered to require endoproteolytic activation (reviewed by Barr, 1991; Steiner et al., 
1992).
Little was known about the nature o f secretory system endoproteases until the 
discovery and cloning o f the KEX2 gene o f Saccharomyces cerevisiae. The product o f 
this gene, Kex2p, also referred to as kexin, was found to share amino acid sequence 
similarity within its catalytic domain to bacterial serine pro teases, which belong to the 
subtilisin family (Fuller et al., 1988, Mizuno et al., 1988). The physiological role o f 
kexin was determined to be processing and activation o f a-m ating factor and killer toxin, 
both activated through intercellular cleavage o f their proproteins at paired basic amino 
acid residues (Fuller et al., 1988). Discovery o f KEX2 led to identification o f the first 
mammalian homologue, which was discovered upstream o f the fes/fps  protooncogene on 
human chromosome 15. The gene, termed fu r  (for c-fes/fps upstream region), coded for 
a putative protein designated furin (Fuller et al., 1989; Roebroek et al., 1986a; Roebroek 
et al. 1986b), which was subsequently shown to be a subtilisin-like serine endoprotease 
(Wise et al., 1990; Bresnahan et al., 1990; Van de Ven et al., 1990).
Following the discovery and characterization o f the fu r  gene and its product, 
experimentation using polymerase chain reaction (PCR) methods led to the discovery o f a 
family o f six fu r-like genes in higher eukaryotes (for reviews see Nakayama, 1997; 
Seidah and Chretien, 1997; Steiner, 1998). Products of these genes are: PC1/PC3 (for 
prohormone or proprotein convertase; hereafter referred to as PC I), PC2, PACE4 (for 
paired basic amino acid cleaving enzyme 4), PC4, PC5/PC6 (hereafter referred to as 
PC5), and LPC/PC7/PC8/SPC7 (hereafter referred to as PC7). These enzymes are
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collectively termed the SPCs (for subtilisin-like proprotein convertases). PC I, PC2, and 
PC4 exhibit a limited pattern o f expression. PCI and PC2 are expressed only in 
neuroendocrine tissue, while PC4 is expressed only in testicular spermatogenic cells 
(reviewed by Nakayama, 1997; Seidah and Chretien, 1997; Steiner, 1998). Furin, 
PACE4, PC5, and PC7 are widely expressed in diverse tissues and cell lines, and are 
believed to function in the constitutive secretory pathway o f many different mammalian 
cell types (reviewed by Nakayama et al., 1997; Seidah and Chretien, 1997; Steiner 1998).
The work described herein focuses on these widely expressed SPCs. Collectively, 
they can endoproteolytically process and activate a number o f proproteins that move 
through the secretory pathway. These proproteins include growth factors, hormones, 
receptors, plasma proteins, and proteins o f the extracellular matrix (Nakayama et al., 
1997; Seidah et al., 1997; Steiner 1998, and references therein). In addition, these SPC 
enzymes also activate proteins that are involved in the development o f disease conditions, 
including viral envelope glycoproteins and bacterial exotoxins (reviewed by Nakayama et 
al., 1997; Seidah et al., 1997; Steiner 1998). Recently, these SPC enzymes have been 
implicated in the activation o f proteins involved in tumor progression and metastasis 
(Bassi et al., 2000).
All SPCs share similar structural features, as shown in Fig. 1 (reviewed by 
Nakayama et al., 1997; Seidah et al., 1997; Steiner 1998). Located at the amino terminal 
end is the signal peptide (SP), which facilitates docking o f ribosomes to the e.r. and 
directs transport o f nascent polypeptides into the e.r. The propeptide (PRO) is 
autocatalytically removed through cleavage at an N-Arg-X-Lys-Arg-C site during
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Figure 1A. Structural components of furin (modified from Spence et al. 1995). Regions of furin, 
from amino-terminus to carboxy-terminus, are as follows: signal peptide (SP), propeptide 
(PRO), catalytic domain (CATALYTIC), Homo-B domain (HOMO B), cysteine-rich 
domain (CRD), and transmembrane domain (TD).
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Figure 1B. Structural comparison of mammalian subtilisin-like pro-protein convertases
(as shown in Nakayama 1997). Schematic representation of the SPCs is shown. The 
percentage of amino acid identity with furin is shown for each region. Single letter amino 
acid abbreviations are used to indicate the propeptide cleavage sequence (RXKR), four 
universally conserved amino acids involved in catalysis (D, H, N, S), and a putative 
integrin-binding motif (RGD/S).
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maturation, thus activating the enzyme. Each o f these enzymes is a serine endoprotease 
with a highly-conserved subtilisin-like catalytic domain containing four universally- 
conserved residues (aspartate, histidine, asparagine, and serine) directly involved in 
catalysis. The Homo-B domain (also referred to as the P or middle domain) is also 
conserved among the SPCs and is essential for enzymatic activity, although its precise 
function remains unclear. Carboxy-terminal to the Homo-B domain is the cysteine-rich 
domain (CRD), a region o f unknown function found in several o f  the SPCs, including 
furin and PACE4. The transmembrane domain (TD), found in several o f  the SPCs, 
anchors the enzyme to membranes o f the secretory system or to the cell surface. The 
cytoplasmic tail, carboxy-terminal to the transmembrane domain, contains amino acids 
that mediate Golgi localization.
Variation exists within structural features among SPCs, and this variation influences 
subcellular localization. Furin and PC7 contain a transmembrane domain, allowing for 
localization to the TGN (Nakayama, 1997). Isoforms o f PC5, generated through 
alternative pre-mRNA splicing, differ in structure and subcellular localization. The 
PC5A isoform lacks a transmembrane domain and localizes to secretory granules 
(Nakagawa et al., 1993; Nakayama, 1997). The PC5B isoform contains a transmembrane 
domain and remains intracellular (Nakagawa et al., 1993; Nakayama, 1997). Localization 
o f PACE4 has not been well characterized. Although PACE4 lacks a transmembrane 
domain, immunochemistry studies suggest that some PACE4 localizes to the TGN 
(Mains et al., 1997). However, transfection experiments show significant levels o f 
PACE4 being both secreted and retained intracellularly (Mains et al., 1997; Sucic et al., 
1999).
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Among the widely expressed SPCs, furin and PACE4 are best characterized. Furin 
processes the widest range o f proproteins and recognizes the cleavage sequence m otif N- 
Arg-X-X-Arg-C. All known proproteins containing this m otif are processed by furin. 
PACE4 recognizes a more specific cleavage sequence m otif o f N-Arg-X-Arg/Lys-Arg-C, 
and can act upon many, but not all, o f the same proproteins as furin. Additionally, not all 
potential substrates containing this consensus cleavage sequence m otif are efficiently 
processed, suggesting that other factors may be involved with substrate recognition by 
PACE4. Thus, PACE4 has a more restricted substrate range than does furin. A list o f 
proproteins containing the cleavage sequence m otif o f PACE4 that are not processed, or 
are poorly processed, by PACE4 is in Table 1. Amino acids are indicated with their three 
letter abbreviations.
The three dimensional structure of subtilisin has been solved through X-ray 
crystallography. This structure was utilized to generate a homology model o f  the catalytic 
domain o f furin (Van de Ven et al., 1990; Seizen et al., 1994). This molecular modeling, 
in conjunction with site-directed mutagenesis studies, has led to predicted interactions 
between substrate amino acids in the P6 through P T  positions and amino acids within the 
catalytic domain o f furin (Seizen et al., 1994). While no molecular model exists for the 
catalytic domain o f PACE4, the 65% amino acid identity between the catalytic domains 
o f PACE4 and furin suggests a similar structure is likely in PACE4. These molecular 
modeling studies also led to a model of the substrate binding region o f furin (Fig. 2). 
This model shows furin and a bound substrate, with “pockets” o f the enzyme occupied by 
side chains o f substrate amino acids. Nomenclature for these pockets is similar to 
nomenclature for substrate amino acid positions; S (substrate binding pocket) is used
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Table 1. Cleavage sequences in proteins not processed, or poorly processed, by 
PACE4 even though the recognition m otif exists
P4 P3 P2 PI
PACE4 Arg X Arg/Lys Arg
Protein P6 P5 P4 P3 P2 P i P L
Factor IX Leu Asn Arg Pro Lys Arg Tyr
RPTPp Gin Gin Arg Pro Arg Arg Thr
HA Lys Lys Arg Glu Lys Arg Gly
Avian HA \ r g Lys Arg Lys Lys Arg Gly
NDV F Gly Arg Arg Gin Arg Phe
gp!60 Val Gin Arg Glu Lys Arg Ala
ST3 Arg Asn Arg Gin Lys Arg Phe
The cleavage recognition motif of PACE4, located above the table, and the amino acids around this motif, 
are defined with specific nomenclature. Substrate residues from the P6 to P I’ positions are indicated with 
their three letter abbreviations. Using pro-factor IX as an example, the PI (Arg) is carboxy-terminal. 
Amino-terminal to the PI is P2 (Lys), amino-terminal to the P2 is P3 (Pro), and amino-terminal to the P3 is 
P4 (Arg). Carboxy-terminal to the PI, amino acids are designated as P I’, P2’, P 3 \ etc. Amino-terminal to 
the P4, amino acids are designated as P5, P6, etc. The site of endoproteolytic cleavage is located between 
the PI and P I’. Proteins are as follows: Factor IX (pro-factor IX), RPTPp (receptor protein tyrosine 
phosphatase ju), HA (human influenza hemagglutinin), Avian HA (avian influenza hemagglutinin), NDV F 
(Newcastle disease virus F protein), gpl60 (human immunodeficiency virus glycoprotein 160), and ST3 
(stromelysin 3). gpl60 and ST3 are processed poorly by PACE4; none of the other substrates are processed 
by PACE4.
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Figure 2. Furin substrate binding region in complex with proprotein model substrate (from Seizen et 
al. 1994). A schematic two-dimensional model o f the substrate binding cleft o f furin based on a 
subtilisin homology model is shown. Thick lines indicate the substrate backbone, thin lines 
represent furin, and dotted lines represent potentialhydrogen bonds between the backbone and 
furin. Amino acids of furin are indicated with their single letter abbreviations. Substrate 
residues from  the P6 to P 2 ’ positions are shown.
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instead o f P. The model also indicates residues o f furin at or near the pockets that are 
proposed to interact with side chains o f substrate residues in positions P6 through P 2 \ 
The four residues highlighted in black boxes are believed to be directly involved in 
catalysis and are completely conserved among the SPCs. Many other residues are also 
conserved in all the SPCs, but some variation exists that may affect 
the interaction between substrate and enzyme, and in turn play a role in mediating 
substrate specificity o f individual SPCs.
Considering the furin substrate binding region model, and sequences shown in Table 
1, some trends for proteins not processed by PACE4 are indicated. Five o f the proteins 
(influenza hemagglutinin, avian influenza hemagglutinin, Newcastle disease virus F 
protein, human immunodeficiency virus glycoprotein 160, and stromelysin 3) have 
hydrophobic residues (glycine, phenylalanine, or alanine; indicated in blue) at the P I ’ 
position. The model indicates that the side chain o f the residue at this position is directed 
toward the solvent, and does not indicate interactions among residues o f furin and the 
P l ’side chain o f the substrate residue. However, if a residue with a hydrophobic side 
chain were at the P I ’ position, the side chain will be repelled from the solvent. This 
repulsion may affect overall conformation o f the substrate backbone, which could affect 
interactions between the substrate and enzyme. This modified backbone conformation 
could impair either the binding o f the substrate to the enzyme or the ability o f the enzyme 
to act upon the bound substrate. Either scenario could affect processing by PACE4. 
Indeed, no known substrates o f PACE4 contain a hydrophobic P I ’ residue. Typically, a 
polar residue such as serine is found in the P I ’ position in PACE4 substrates. Three 
proteins (pro-factor IX, Newcastle disease virus F protein, and human immunodeficiency
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virus glycoprotein 160) have residues with hydrophobic side chains (leucine, glycine, or 
valine; indicated in red) at the P6 position. In the S6 pocket, the model contains two 
residues having highly charged side chains, aspartic acid (D157; shown in Fig. 2) and 
lysine 154 (not shown in Fig. 2, but described by Seizen et al.), into close proxim ity with 
the side chain o f the P6 amino acid. In PACE4, both o f these residues are conserved. If 
the P6 residue side chain is hydrophobic, it would be unable to interact with the highly 
charged residues o f the S6 pocket. In this scenario, the substrate might not bind to the 
enzyme as efficiently as a substrate with a P6 residue that could interact with residues o f 
the S6 pocket, thus resulting in a decrease in processing efficiency. No known PACE4 
substrates contain leucine, glycine, or valine in the P6 position. Finally, the presence o f 
hydrophobic residues in both the P I ’ and P6 positions, which is the case for two proteins 
(Newcastle disease virus F protein and human immunodeficiency virus glycoprotein 160) 
may have an even greater effect on substrate binding or chemical catalytic rate. Two 
proteins (pro-Factor IX and receptor protein tyrosine phosphatase p) have a proline at the 
P3 position (indicated in violet). The unusual side chain o f proline prevents free rotation 
around the amino acid’s a  carbon and imposes structural rigidity that could impact 
conformation o f the substrate backbone. Such a proline could negatively affect the ability 
o f  the substrate to bind to the enzyme or alter the alignment o f a bound substrate, thus 
adversely affecting catalytic activity.
Currently, little is known about the substrate selectivity o f PCS and PC7, although 
these endoproteases may have restricted substrate ranges compared to furin. From 
examinations done with protein substrates, PC5 is proposed to have a cleavage sequence 
m otif o f N-Arg-X-X-Arg-C (Duguay et al., 1997; Nachtigal and Ingraham, 1996; Cui et
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al., 1998). PC7 is also proposed to have an N-Arg-X-X-Arg-C cleavage sequence motif, 
which was determined through use o f synthetic fluorescent substrates (M unzer et al., 
1997).
These widely expressed SPCs play critical physiological roles in normal 
development through activation of several hormones, blood proteins, growth factors, 
receptors, and proteins o f the extracellular matrix (Nakayama, 1997; Seidah and Chretien, 
1997; Steiner, 1998). Additionally, these enzymes activate proteins involved in the 
development o f disease conditions, including viral glycoproteins, bacterial toxins, and 
proteins involved in tumor progression (Nakayama, 1997; Seidah and Chretien, 1997; 
Steiner, 1998). Specific physiological or pathological roles for individual SPCs have 
been difficult to determine, as SPCs often show functional redundancy, i.e. a protein can 
be activated by more than one SPC. However, substrate selectivity is also seen, where 
only one or two o f the SPCs can activate a particular substrate protein. Determination o f 
underlying mechanisms for substrate selectivity o f SPCs is o f key importance for gaining 
insight into the role(s) o f each SPC. Considering the role o f SPCs in activating bacterial 
toxins and viral proteins, development o f specific inhibitors for these enzymes—  
particularly for antiviral purposes— has also become a focus o f intense research interest. 
Design o f specific inhibitors could be greatly facilitated by understanding mechanisms 
that mediate substrate specificity in SPCs.
I proposed to focus my interests in this study on the hydrophobic residues o f the P I ’ 
position, to determine if they are involved in substrate selectivity o f the four widely 
expressed SPCs. To test this hypothesis, the precursor o f the blood clotting protein, von 
Willebrand Factor (pro-vWF), a substrate efficiently processed by all four widely
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expressed SPCs, was used. Cleavage site residues o f pro-vWF, and their numerical 
positions in the pro-vWF primary structure, are shown in Table 2. Residue substitutions, 
which incorporated glycine, alanine, and phenylalanine, at the P I ’ position were 
generated through use o f site-directed mutagenesis.
Expression constructs incorporating these changes, along with expression constructs 
containing complementary DNA (cDNA) coding for the four widely expressed SPCs, 
were transfected into RPE.40 cells, a mutant strain o f CHO-K1 (Chinese Hamster Ovary 
Strain K l) cells characterized by a resistance to Pseudomonas exotoxin A (PEA) 
(M oehring and Moehring, 1983). RPE.40 cells harbor mutations within the fu r  alleles 
that lead to production o f non-functional furin; as a result, RPE.40 cells are furin null 
(Spence et al., 1995; Sucic et al., 1998). These cells are also believed to be PACE4 null 
(Sucic et al. 1998), but may express minimal levels o f PC5 and PC7 (Duguay et al., 
1997). Thus, these endoprotease-deficient cells fail to activate PEA and also fail to 
process many expressed proproteins. RPE.40 cells provide an ideal vehicle for analyzing 
pro-vW F processing by SPCs, as removal o f the propeptide o f pro-vWF, essential for 
function, is not required for secretion. Removal o f the propeptide also causes a 
significant molecular weight shift upon SDS-PAGE, from 350 kilodaltons (kDA) in pro- 
vWF to 250 kDa in mature vWF. Therefore, conditioned medium containing secreted 
vWF protein(s) from transfected RPE.40 cells can be analyzed for presence o f processing 
by the four SPCs.
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Table 2. Cleavage site sequence and codons of pro-von W illebrand Factor
P6 P5 P4 P3 P2 PI P I ’
Residue # 758 759 760 761 762 763 764
Residue Ser His Arg Ser Lys Arg Ser
wt pro-vWF codons TCT CAT CGC AGC AAA AGG AGC
P I ’alanine mutant codons TCT CAT CGC AGC AAA AGG GCC
P I ’ phenylalanine mutant codons TCT CAT CGC AGC AAA AGG TTC
P I ’glycine mutant codons TCT CAT CGC AGC AAA AGG GGC
Residues for pro-vW F from the P6 to P I ’ positions are indicated with their three letter abbreviations. 
Codons for each position are shown for wild type (wt) pro-vW F and the three P I ’ mutants ( P l ’alanine, 
P l ’phenylalanine, and P I ’ glycine).
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Materials and Methods
M aterials
Unless otherwise specified, all enzymes were purchased from Gibco-BRL 
(Gaithersburg, MD). Unless otherwise specified, all chemicals were obtained at the 
highest purity available from Fisher Scientific (Pittsburgh, PA).
Plasmids
pBluescipt KS (pBS) was purchased from Stratagene (La Jolla, CA). The cDNA 
encoding human PACE4 was cloned into the expression plasmid pSVL as described 
earlier (Sucic et al., 1999). The cDNA encoding wild type CHO-K1 furin was cloned into 
the expression plasmid pcDNA3 as described previously (Spence et al. 1995). An 
expression vector directing production o f mouse PC5 (the secreted PC5A isoform) was a 
generous gift from Dr. Kazuhisa Nakayama (Institute o f Biological Sciences, University 
o f Tsukuba; Tsukuba, Ibaraki, Japan). An expression vector directing production o f 
mouse PC7 was a generous gift from Dr. Kumar Sambamurti (Department o f 
Pharmacology, Mayo Clinic; Jacksonville, FL). An expression vector directing 
production o f human pro-vWF (pSVL-vWF) was a generous gift from Dr. Jan A. van 
Mourik and Dr. Jan Voorberg o f the Central Laboratory o f the Netherlands Red Cross 
Blood Transfusion Service (Amsterdam, The Netherlands).
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Site-directed M utagenesis to Incorporate Glycine and Phenyalanine P I’ Changes
Site-directed mutagenesis was performed using the QuikChange system (Stratagene). 
Oligonucleotide mutagenic primers, designed according to QuikChange specifications, 
were purchased from Gibco-BRL and reconstituted and stored as directed by the supplier. 
The QuikChange system was used according to manufacturer specifications, with the 
following recommended modifications from contact with technicians at Stratagene: 170 
ng o f  pSVL-vW F used (as opposed to 50 ng), 250 ng o f each oligonucleotide prim er used 
(as opposed to 125 ng), 20 PCR cycles with 1 jllL PfuTurbo DNA polymerase added at 
beginning o f 10th PCR cycle (as opposed to 12 PCR cycles and no additional DNA 
polymerase), and ethanol precipitation and concentration o f DNA after mutagenesis 
reactions and prior to transformation into Epicurian Coli XL 1-Blue supercompetent cells 
(which allowed transformation o f all o f the DNA from each mutagenesis reaction). These 
modifications were recommended due to the large size o f the pro-vWF cDNA insert [8.8 
kilobase pairs (kb)] and the correspondingly large size (13 kb) o f the pSVL-vW F 
construct, as the QuikChange system is optimal for plasmids less than 10 kb.
Glycerol Stocks
Samples o f bacterial cells harboring plasmids o f interest were grown overnight in 
Luria-Bertani (LB) broth containing 200 pg/mL ampicillin. Cells were preserved at 
-70°C after adjusting overnight cultures to 15% glycerol.
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Plasm id Preps and Analysis
Colonies derived from transformed Epicurian Coli X Ll-B lue cells were propagated 
in 5 mL LB broth, containing 200 pg/mL ampicillin, at 37°C for > 16 hours. The 
QIAprep Spin Miniprep Kit (QIAGEN; Valencia, CA) was used to purify plasmid DNA 
from these cells, following manufacturer instructions. Restriction digests with Kpn I 
were performed and samples were resolved using 1% agarose gels in 0.5x TBE (45 mM 
Tris-Borate, 1 mM EDTA) to confirm the presence o f pSVL-vWF, which shows three 
discrete bands [7 kb, 4.7 kb, and 1.7 kb] upon Kpn I digestion. Automated sequencing to 
verify presence o f the mutations was done by the University o f M ichigan DNA 
Sequencing Core Facility (University o f Michigan; Ann Arbor, MI). The Concert High 
Purity Plasmid Midiprep System (Gibco-BRL) was used to purify larger quantities o f 
DNA for subsequent use in transfections. For Midipreps, Epicurian Coli X Ll-B lue cells 
harboring plasmids o f interest were propagated in 30 mL LB broth, containing 200 pg/mL 
ampicillin, at 37° C for > 16 hours with rapid (>250 rpm) shaking for aeration.
Incorporation of the Alanine P I’ Change
Analysis o fpro-vW F  cDNA fo r  Subcloning and Site-directed Mutagenesis
Incorporation o f the alanine PU change was difficult. Initial attempts were made 
using the QuikChange system, which was successful for incorporation o f the PU  glycine 
and phenylalanine changes; however, even with the aforementioned modifications, 
generation o f the alanine PU change was unsuccessful. An alternative strategy was 
therefore developed that involved subcloning a fragment o f pro-vWF cDNA containing 
the mutagenesis target sequences into pBS (a plasmid o f smaller size than pSVL),
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incorporating the mutation with site-directed mutagenesis, and reintroducing the mutant 
fragment back into the pSVL-vWF backbone.
The MapDraw application o f Lasergene software (DNASTAR; M adison, W isconsin) 
was used to examine the pro-vWF cDNA and pSVL sequences for restriction sites that 
would allow subcloning o f a fragment containing the mutagenesis target sequences. Two 
Pvu I restriction sites were discovered, which produce a 5.5 kb fragment (containing the 
desired mutagenesis sites) and an 8 kb fragment. These restriction sites are located in the 
pro-vW F cDNA and the ampicillin resistance (AmpR) gene carried by pSVL (Fig. 3).
MapDraw (DNASTAR) was also used to examine pBS for Pvu I restriction sites that 
would allow introduction o f the pSVL-vWF fragment into pBS. Two restriction sites 
were found, producing a 1.9 kb backbone fragment and a 1 kb by-product fragment (Fig. 
4). Utilizing only Pvu I allowed for insertion o f the pSVL-vWF fragment into the pBS 
backbone in two orientations. However, as with pSVL, one o f the two Pvu I sites in pBS 
is located in the AmpR gene, which is an ideal location, as the 5.5 kb fragment from 
pSVL-vW F can be introduced into pBS in an orientation that will correctly reform the 
A m pR gene. Thus, in subsequent transformations, a selection method was in place for 
“correctly” ligated plasmids, as only transformed cells with the pSVL-vW F fragment in 
the correct orientation would propagate in the presence o f ampicillin.
Restriction Digests and Purification o f  DNA
To produce the desired fragments for subcloning, restriction digests were performed 
using Pvu I on pSVL-vWF and pBS, and samples were resolved using 1% agarose gels in
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Mutagenesis Sites
I
vWF cDNA
Pvu I
SV40 Late Promoter—>
Pvu I
T
AmpR
Figure 3. Pvu I restriction sites in pSVL-vWF. Two Pvu I restriction sites are indicated; one is
located in the AmpR gene, while the other is in the pro-vWF cDNA. Mutagenesis sites for the 
PI ’ residue are indicated in black.
Pvu I
Amp
,<= Pvu I
2.9 kb
on
Figure 4. Pvu I restriction sites in pBS. Two Pvu I restriction sites are indicated; one is located in the 
AmpR gene, while the other is near the multiple cloning site (MCS). The origin o f replication 
(ori) is also indicated.
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lx  TAE (40 mM Tris-Acetate, 1 mM EDTA). Bands representing the fragments o f 
interest were viewed using long wave (320 nm) UV light, excised with a sterile razor 
blade, and purified utilizing the Wizard PCR Preps DNA Purification System (Promega; 
Madison, WI) according to manufacturer specifications. Verification o f DNA o f  interest 
and approximate molar concentrations were determined by examining the purified 
fragments with a 1% agarose gel (TBE).
Ligations and Transformations
Ligations were performed to incorporate the pSVL-vWF fragment into pBS, using 
T4 DNA Ligase (Gibco-BRL) and equimolar concentrations o f the pBS and pSVL-vW F 
fragments. Ligation reactions were incubated at 16° C for > 12 hours, and 5 pL o f  each 
reaction was used to transform E. coli X Ll-Blue competent cells produced according to 
standard protocols (Sambrook et al., 1989). Following addition o f ligation products, cells 
were incubated on ice for 20 minutes, heat shocked at 42° C for 2 minutes, and incubated 
at 37° C for 1 hour following addition of 950 pL o f LB broth. Transformed cells (200 
pL) were plated on LB agar, containing 200 pg/mL ampicillin, and grown at 37° C for > 
16 hours.
Plasmid Preps and Analysis
Colonies obtained following transformations were used to start cultures (in LB broth 
containing 200 pg/mL ampicillin) for small scale plasmid isolations. The QLAprep Spin 
Miniprep Kit (QIAGEN) was used to purify plasmid DNA from ligation reactions. 
Restriction digests with Pvu I were performed and samples were resolved using 1%
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agarose gels (TBE) to confirm proper digestion o f pBS carrying the pro-vW F insert, 
which showed two discrete bands (5.5 kb and 1.9 kb) upon Pvu I digestion.
M utagenesis with pB S  containing pro-vW F fragm ent
Site-directed mutagenesis was performed using the QuikChange system (Stratagene). 
M utagenesis reactions and subsequent transformations were performed according to 
manufacturer specifications, with no modifications.
Plasm id Preps and Analysis
Colonies obtained following transformations were used to start cultures (in LB broth, 
containing 200pg/mL ampicillin) for small scale plasmid isolations. The QIAprep Spin 
Miniprep Kit (QIAGEN) was used to purify plasmid DNA (pBS with pro-vW F insert) 
from mutagenesis reactions, as described earlier. Restriction digests with Pvu  I were 
performed and samples were resolved using 1% agarose gels (TBE) to confirm proper 
digestion o f pBS with pro-vWF insert. Automated sequencing to verify presence o f the 
mutation was done by the University o f Michigan DNA Sequencing Core Facility.
Reintroduction o f  mutated pro-vW F fragm ent hack into pSVL
Pvu I restriction digests were performed on pSVL-vWF and pBS with pro-vWF 
insert, and samples were resolved using 1% agarose gels (TAE). Bands on agarose gels 
containing fragments o f interest were viewed using long wave UV light (320 nm), 
excised with a sterile razor blade, and purified utilizing the Wizard PCR Preps DNA 
Purification System (Promega). Verification o f DNA of interest and approximate molar
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concentrations were determined by examining each purified fragment with a 1% agarose 
gel (TBE).
Ligations and Transformations
Ligations were performed to incorporate the mutant pSVL-vWF fragment back into 
pSVL, using T4 DNA ligase and equimolar concentrations o f DNA, as described earlier. 
Ligation products were transformed into E. coli XL 1-Blue cells as described above.
Plasm id Preps and Analysis
Colonies obtained following transformations were used to start cultures (in LB broth, 
containing 200 pg/mL ampicillin) for small scale plasmid isolations. The QIAprep Spin 
M iniprep Kit (QIAGEN) was used to purify plasmid DNA from ligation reactions, and 
restriction digests with Kpn I were performed to confirm proper digestion o f  pSVL-vW F, 
as described earlier.
Mammalian Cell Culture
CHO-K1 and RPE.40 cells were maintained in Dulbecco’s modification to Eagle’s 
Minimal Essential Medium (D-MEM/F-12) supplemented with 7.5% fetal bovine serum 
(FBS), non-essential amino acids (NEAA; diluted to lx from a lOOx stock obtained from 
Gibco-BRL), 0.05mg/mL gentamicin, and 0.25 pg/mL fungizone. Cells were maintained 
in a humidified atmosphere o f 4-4.5% C 0 2 at 37°C.
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Transfections
Either 5 x 105 RPE.40 cells were plated in 60 mm x 15 mm (P60) tissue culture 
dishes or 2 x 105 RPE.40 cells were plated in 35 mm x 10 mm (P35) tissue culture dishes. 
Cells were incubated for 16 hours prior to transfections. Lipofectamine reagent (Gibco- 
BRL) was used according to manufacturer’s instructions, with either 3 p.g DNA (P60s) or 
1.2 pg DNA (P35s). For coexpression experiments, 3 pg DNA (P60s) o f each construct 
or 1.2 pg DNA (P35s) o f each construct was used. Transfected cells were incubated for 
60 hours and conditioned medium containing vWF was then collected for analysis.
SDS-PAGE and Western Blotting to Analyze pro-vWF Processing
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed on conditioned medium samples from transfections, as described previously 
(Laemmli, 1970), under denaturing conditions with a 5% (w/v) polyacrylamide resolving 
gel. Resolved proteins were transferred to Immobilon-P membranes (Millipore 
Corporation; Bedford, MA). Western blot analysis was performed as described 
previously (Sucic et al., 1998), using a rabbit anti-human vWF polyclonal antibody 
(DAKO Corporation; Carpinteria, CA), and anti-rabbit IgG alkaline phosphatase 
conjugate and alkaline phosphatase substrate/detection reagents obtained from Promega.
In vitro Processing Reactions
RPE.40 cells stably over-expressing each o f the four SPCs were used as sources of 
individual enzymes. For reactions requiring PACE4 and PC5, conditioned medium from
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RPE.40 cells stably over-expressing these SPCs was used, as cells expressing PACE4 and 
PC5 secrete large amounts o f these endoproteases (Sucic et ah, 1999; also unpublished 
results). Conditioned medium was also used as a source for furin, as a secreted, truncated 
form of furin was generated and stably over-expressed in RPE.40 cells (Sucic et al., in 
preparation). Membrane fractions containing fragments o f e.r. and Golgi apparatus were 
used in reactions requiring PC7. Isolation o f these fractions was performed on cells 
stably expressing PC7 (B.A. Ziemba and J.F. Sucic, unpublished) as described previously 
(Inocencio et al., 1994). Substrates for the reactions were either wild type or mutant 
forms o f pro-vWF generated by RPE.40 cells. Reactions contained lx  in vitro processing 
(IVP) buffer [10 mM HEPES (pH 7.3), 3 mM CaCl2, and 0.1% Triton X-100], substrate 
proprotein, and equivalent amounts of conditioned medium or membrane fractions 
containing SPC activity. Reactions were incubated at 37° C for 16 hours using the dwell 
temperature application o f an Amplitron II thermocylcer (Bamstead/Thermolyne; 
Dubuque, IA). Reaction products were subjected to SDS-PAGE and W estern blotting as 
described above.
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Results
In vivo processing o f  mutant form s ofpro-vW F by widely expressed SPCs
Lipofectamine transfection experiments were performed using RPE.40 cells. M utant 
forms o f pro-vWF, harboring the P I ’ substitutions, were expressed in RPE.40 cells 
individually or in tandem with each widely expressed SPC. Transfected cells were 
incubated for 60 hours, and conditioned medium containing vWF was collected for 
analysis. Proteins were resolved by SDS-PAGE, and vWF was detected using W estern 
blotting.
Results are shown in Fig. 5. The blot labeled RPE.40 shows the results obtained 
when cells were transfected only with the various pro-vWF constructs; no SPCs were 
coexpressed. As a result, no processing o f pro-vWF into mature vWF was observed, 
consistent with earlier work in which pro-vWF had been expressed (Sucic et al., 1998). 
The remaining four blots show results o f coexpression experiments. Interestingly, furin 
and PACE4 processed wild type pro-vWF and each o f the P I ’ mutants in a consistent 
pattern. Wild type pro-vWF was completely or nearly completely processed, as was the 
version o f pro-vWF harboring the P I ’ alanine. Processing o f pro-vWF harboring a P I ’ 
glycine was slightly impaired, while processing o f pro-vWF containing a P I ’ 
phenylalanine was more significantly impaired. These results were unexpected, 
considering that furin has been shown to efficiently process several proteins containing 
P I ’ hydrophobic residues, including phenylalanine (Nakayama, 1997). PC5 efficiently 
processed wild type pro-vWF and the mutant versions containing PI ’ alanine
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Figure 5. In vivo processing of pro-vWF proteins harboring PP substitutions. RPE.40 cells were used 
in transfection experiments in which expression plasmids coding for the various forms o f  pro- 
vWF were introduced individually, or in tandem, with expression plasmids coding for one o f the 
SPCs. Cells were incubated for 60 hours, media was collected, proteins were resolved using 
SDS-PAGE, and vWF was detected using Western blotting. The blot labeled RPE.40 shows 
results o f expressing the forms o f pro-vWF in RPE.40 cells without coexpression o f  an SPC; the 
remaining four blots state the SPC used. Listed above each blot are the various forms o f  vWF 
used. Wild type (wt) vWF is in lane 1; lanes 2-4 contain mutant forms o f vWF, in which the P P  
residue (S764) has been altered to the residue specified (A-alanine, F-phenylalanine, or G- 
glycine). Relative positions o f pro-vWF and mature vWF are indicated.
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and glycine residues. Processing o f pro-vWF harboring a PI ’ phenylalanine was slightly 
impaired, which was another surprising result since PC5 has been shown to process at 
least one substrate containing a P I ’ phenylalanine. PC7 processed all versions o f  pro- 
vW F very inefficiently, with no observable differences between the wild type version and 
the PI ’ mutants.
In vitro processing o f  mutant form s ofpro-vW F by widely expressed SPCs
An inherent weakness o f coexpression experiments is that the different SPCs have 
varying opportunities to process substrate proproteins, depending upon the subcellular 
distribution o f the enzyme. For example, much more PACE4 is secreted by transfected 
cells than furin (Sucic et al., 1999). Also, the PC5A isoform was used in coexpression 
studies, and all o f the PCS produced by the transfected cells was secreted (Nakagawa et 
al., 1993). In contrast, PC7 is strictly intracellular. Therefore, the processing activities 
observed for PACE4, PC5, and to some extent furin, may be over-represented relative to 
PC7, because secreted versions o f these enzymes could process secreted pro-vW F over 
the 60 hour time course o f the experiment— even if the version o f pro-vWF is a “poor” 
substrate for the enzyme. In an effort to address this weakness, the ability o f SPCs to 
process the different versions o f pro-vWF in vitro was examined.
RPE.40 cells stably expressing each o f the four SPCs were used as sources o f 
individual enzymes. Conditioned medium was used as sources o f PACE4, PCS, and the 
secreted form o f furin. Membrane fractions containing e.r. and Golgi components were 
used in reactions requiring PC7. These enzyme sources were examined for 
endoproteolytic activity versus wild type and mutant forms o f pro-vWF under previously
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described in vitro processing reactions (Inocencio et al., 1994). Reaction products were 
resolved using SDS-PAGE, and vWF was detected using Western blotting.
Results o f in vitro processing reactions are shown in Fig. 6. The blot labeled RPE.40 
is a control, as conditioned medium from untransfected RPE.40 cells was used versus the 
different version o f pro-vWF. As expected, no processing o f pro-vWF into mature vWF 
was observed. The remaining four blots show in vitro processing by conditioned medium 
or membrane fractions from cells stably expressing the SPCs. Very similar in vivo 
processing was observed for furin, PACE4, and PCS. Each enzyme showed significant 
processing o f wild type pro-vWF. Processing o f pro-vWF harboring a P I ’ alanine or 
PI ’glycine appeared to be slightly impaired, while processing o f pro-vWF containing PI ’ 
phenylalanine was significantly impaired. Results o f in vitro processing reactions using 
PC7 showed approximately equivalent levels o f processing o f all four substrates, as was 
observed in results from in vivo experiments. These results may indicate a broader 
substrate range for PC7, with the P I ’ pro-vWF mutants having no negative effect on 
processing.
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Figure 6. In vitro processing of pro-vWF proteins harboring P I’ substitutions. RPE.40 cells stably 
expressing each o f  the four SPCs were used as sources o f individual enzymes and the various 
forms o f pro-vWF. Conditioned medium was used as sources o f PACE4, PC5, and secreted 
furin. Membrane fractions were used in reactions requiring PC7. Reactions were incubated for 
16 hours, proteins were resolved using SDS-PAGE, and vWF was detected using W estern 
blotting. Listed above each blot are the various forms o f vWF used. Wild type (wt) vW F is in 
lane 1. Lanes 2-4 contain mutant forms of vWF. in which the PI ’ residue (S764) has been 
altered to the residue specified (A-alanine, F-phenylalanine, or G-glycine). The blot labeled 
RPE.40 shows control results in which conditioned medium from RPE.40 cells was used; the 
rest o f the blots state the SPC used. Relative positions of pro-vW F and mature vW F are 
indicated.
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Discussion
Recent research on endoproteolysis by the widely expressed eukaryotic SPCs has 
mostly focused on two members, furin and PACE4, while much less characterization has 
been done on the more-recently discovered PC5 and PC7. Furin has been well- 
characterized, and is described as having a substrate cleavage recognition m otif o f N-Arg- 
X-X-Arg-C (Nakayama, 1997); when this m otif is present, furin efficiently processes the 
substrate proteins (Nakayama, 1997). Protein processing by PACE4 is more limited, as 
its cleavage recognition m otif o f N-Arg-X-Arg/Lys-Arg-C (Creemers et al., 1993; 
Rehemtulla et al., 1993; Hosaka et al., 1994) places restrictions on substrate specificity. 
Furthermore, several potential substrates that contain the PACE4 cleavage recognition 
m otif are not processed, or are poorly processed, by PACE4 (Table 1). This lack o f 
processing, even though the recognition m otif is present, suggests that residues outside 
the cleavage recognition m otif play a role in substrate selectivity. Five o f these non­
processed substrates contain a hydrophobic residue (alanine, phenylalanine, or glycine) in 
the PI ’ position, directly downstream from the site o f endoproteolytic cleavage, while the 
PI ’ residue in most substrates acted upon by PACE4 is a polar residue like serine. I have 
hypothesized that during substrate binding, side chains o f hydrophobic residues in this 
position are repelled from the solvent, thus affecting the overall conformation o f the 
substrate backbone and affecting interactions between the substrate and the enzyme. 
Changing the nature o f these interactions could result in either inefficient substrate 
processing, or complete abolition o f processing, by the enzyme. To determine the role of 
the amino acid directly downstream from the site o f endoproteolytic cleavage, P I ’ amino
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acid substitutions were made in pro-vWF, a substrate processed by all four o f  the widely 
expressed SPCs. Three mutant forms o f pro-vWF, harboring P I ’ alanine, P I ’ 
phenylalanine, or P I ’ glycine residues, were generated via site directed mutagenesis 
(Table 2, page 12). These mutant forms o f pro-vWF were examined as substrates for 
furin, PACE4, and the two other widely expressed SPCs, PC5 and PC7. It has been 
proposed that PC5 and PC7 have a cleavage sequence m otif o f N-Arg-X-X-Arg-C 
(Duguay et al., 1997; Nachtigal and Ingraham, 1996; Cui et al., 1998; M unzer et al., 
1997), although little information is currently available about the substrate range o f these 
enzymes.
Results from experiments in vivo and in vitro suggest that a P I ’ hydrophobic residue 
impacts processing. Surprisingly, processing o f mutant forms o f pro-vWF by furin and 
PACE4 was nearly indistinguishable (Fig. 5 and 6). These SPCs completely, or nearly 
completely, cleaved the P I ’ alanine and P I ’ glycine pro-vWF mutants, but processing o f 
the PI ’ phenylalanine mutant was significantly impaired. Nonetheless, the presence o f a 
phenylalanine in the P I ’ position, by itself, does not appear to play a role in substrate 
selectivity, at least with the pro-vWF substrate. While Newcastle disease virus F protein, 
which also contains a P I ’ phenylalanine, is not processed by PACE4 (Fujii et al., 1999), 
and stromelysin 3, which likewise contains a P I ’ phenylalanine, is poorly processed by 
PACE4 (Santavicca et al., 1996), both substrates are cleaved by furin. These findings, in 
conjunction with my results, suggest that substrate residues or broader structural features 
other than the P I ’ residue and the cleavage recognition m otif are playing a role in 
substrate selectivity. Further experimentation is needed to reconcile the results obtained 
with the pro-vWF proteins carrying P I ’ substitutions and results generated in other
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laboratories with naturally-occurring substrates. Further experimentation is also needed 
to determine the precise biochemical basis o f the impaired processing observed with the 
PI ’ phenylalanine substitution. The presence of the phenylalanine may impact substrate 
binding or may decrease catalytic efficiency o f the SPC on the bound substrate.
Processing o f wild type and mutant forms o f pro-vWF by PC5 also yielded an 
unexpected result, observed both in vivo and in vitro. PC5 efficiently processed wild type 
pro-vW F and the mutant versions harboring a P I ’ alanine or glycine, but processing o f 
pro-vW F containing a P I ’ phenylalanine was impaired. In contrast to these findings, 
published results show that PCS can process Newcastle disease virus F protein, which 
contains a P I ’ phenylalanine (Fujii et al., 1999). My results, and these published results 
for substrate processing by PC5, suggest, as was earlier stated, that structural features 
other than the P I ’ residue and the cleavage recognition m otif are playing a role in 
substrate specificity.
The processing o f the pro-vWF mutants harboring the P I ’ alanine, P I ’ 
phenylalanine, and P I ’ glycine by furin, PACE4, and PCS, suggest possible courses for 
future experimentation. Analysis o f the P6 substrate residues o f Newcastle disease virus 
F protein and human immunodeficiency virus glycoprotein 160 indicates the presence o f 
a hydrophobic residue (glycine and valine, respectively), while both o f these substrates 
also have a P I ’ hydrophobic residue (phenylalanine and alanine, respectively). This 
combination o f hydrophobic P I ’ and P6 residues may play a more important role in 
mediating substrate selectivity in these SPCs, in contrast to the presence o f a P I ’ 
hydrophobic residue alone. Using pro-vWF as a substrate, substitutions o f the P6 residue 
with hydrophobic residues, in combination with the three hydrophobic mutants generated
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in this study, could be tested against each o f widely expressed SPCs. Indeed, this 
experimentation is a long-term goal o f the research in Dr. Sucic’s laboratory.
The substrate range and specificity o f PC7 have not yet been extensively 
investigated. Results from this study suggest PC7 may have a broader substrate range 
than the other widely expressed SPCs. Although not well demonstrated in vivo, in vitro 
processing o f the three P I ’ mutant forms o f pro-vWF by PC7 was equivalent to that o f 
wild type pro-vWF, in contrast to the results obtained with furin, PACE4, and PC5 (Fig. 5 
and 6). The apparent lack o f processing o f the various forms o f pro-vWF by PC7 in vivo 
was likely due to the limited interaction of pro-vWF and PC7 in the Golgi apparatus. 
Recall that unlike the other SPCs used in this study, PC7 is exclusively localized 
intracellularly and therefore may have less opportunity to act upon pro-vW F in 
coexpression experiments.
RPE.40 cells are endoprotease deficient, but can process some proproteins. PC7 is a 
likely candidate for carrying out these activities, as RPE.40 cells express low levels o f 
PC7 (Duguay et al., 1997). RPE.40 cells have been shown to endoproteolytically cleave 
the P-site amyloid precursor protein cleaving enzyme, also called the Alzheim er’s (3 
secretase (Pinnix et al., 2001), and pro-insulin-like growth factor 1 (Duguay et al. 1997). 
Diphtheria toxin, known to be processed by furin and PACE4 (Nakayama, 1997; Sucic et 
al., 1999), may also be processed by PC7, as RPE.40 cells are sensitive to diphtheria 
toxin (Moehring and Moehring, 1983). Direct processing o f these substrates by PC7 has 
not been demonstrated, and will need to be investigated in future studies. Alternatively, 
representation o f these substrates, by incorporation o f amino acid substitutions into pro-
33
vWF, may allow the substrate specificity o f PC7 to be further characterized, through in 
vivo and in vitro techniques like those utilized in these studies.
Another substrate processed by RPE.40 cells is the human immunodeficiency virus 
glycoprotein 160, which has been thoroughly studied. Upon cleavage and subsequent 
activation by cellular endoproteases into gpl20  and gp41, the envelope glycoprotein 
initiates infection through fusion o f the viral envelope with the cell membrane 
(Hallenberger et al., 1992). Early in vivo studies had implicated furin as important for the 
cleavage o f gpl60  (Hallenberger et al., 1992; Decroly et al., 1994; Gu et al., 1995). More 
recent work suggested that furin is not the primary enzyme found to be processing gpl60. 
Processing o f gp l60  was not increased when furin was overexpressed in RPE.40 cells, 
and in vitro evidence for a calcium-independent gpl60 processing enzyme was obtained 
from in vitro reactions (Inocencio et al., 1997). Examination o f lymphatic tissues and 
cells, which interact with gpl60 in the development o f HIV infection, showed the 
presence o f furin and PC7, but no other SPCs. Coexpression experiments, utilizing these 
natural host cells, with gpl60 and furin or PC7, demonstrated gpl60  processing by both 
SPCs (Hallenberger et al. 1997). The likely presence o f PC7 in RPE.40 cells could then 
explain their processing o f gpl60.
Future experimentation would allow examination of the effects o f a P3 proline on 
substrate selectivity. Two substrates not processed by PACE4, pro-factor IX and receptor 
protein tyrosine phosphatase p, have a P3 position proline. These proteins are processed 
by furin, while processing o f these proteins by PC5 and PC7 is unknown. Incorporation 
o f a single residue substitution in the P3 position of pro-vWF, and a combination o f a P3
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position proline with a hydrophobic residue in the P6 position, as is found in the substrate 
pro-factor IX, would allow determination o f processing by PACE4, PC5, and PC7.
This study has initiated analysis o f substrate selectivity o f the SPCs, and the effects 
o f residues outside the cleavage recognition m otif Results demonstrate that the presence 
o f a PI ’ hydrophobic residue alone is not involved in substrate specificity o f some o f the 
widely expressed SPCs. Activity of furin, PACE4, and PC5 was significantly impaired 
by the presence o f a P I ’ phenylalanine. These results, in conjunction with studies from 
other laboratories, suggest that the residue residing in the P l ’position does not solely 
determine substrate specificity o f the SPCs. These results suggest that further 
investigation is required to determine the effects o f combinations o f hydrophobic 
residues, in the P I ’ and P6 residue locations, on substrate selectivity o f the SPCs. In 
addition, effects o f proline in the P3 position, and studies focused upon further 
characterization o f PC7, can now be undertaken.
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